Maia Biotechnology Inc (MAIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,117 | -15,769 | -11,624 | -6,720 | -3,414 |
| Accounts payable and accrued liabilities | -35 | 211 | 65 | 91 | -67 |
| Other Working Capital | 76 | 353 | -325 | 594 | -107 |
| Other Operating Activity | 716 | 3,109 | 2,737 | 1,207 | 780 |
| Operating Cash Flow | $-3,361 | $-12,096 | $-9,146 | $-4,827 | $-2,808 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 14,443 | 14,425 | 2,907 | 2,531 |
| Other Financing Activity | 0 | -1,966 | -1,755 | -496 | 0 |
| Financing Cash Flow | $N/A | $12,477 | $12,670 | $2,411 | $2,531 |
| Exchange Rate Effect | -4 | -4 | -34 | -8 | -4 |
| Beginning Cash Position | 10,951 | 10,574 | 10,574 | 10,574 | 10,574 |
| End Cash Position | 7,586 | 10,951 | 14,064 | 8,150 | 10,294 |
| Net Cash Flow | $-3,365 | $377 | $3,489 | $-2,424 | $-281 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,361 | -12,096 | -9,146 | -4,827 | -2,808 |
| Free Cash Flow | -3,361 | -12,096 | -9,146 | -4,827 | -2,808 |